Guest guest Posted October 2, 2008 Report Share Posted October 2, 2008 this does look promising! Trial of second-generation zanamivir shows promise Schnirring * Staff Writer Aug 1, 2008 (CIDRAP News) – Two pharmaceutical companies that are developing a second-generation version of the inhaled antiviral drug zanamivir (Relenza) reported promising phase 2 results showing that one dose was as effective against influenza as a course of oseltamivir (Tamiflu)... Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.